Versatility of Cyclooctadiene Ligands
Organometallics, Vol. 22, No. 26, 2003 5415
Cl2, 293 K): δ 1.52 (d, J HP ) 8.2, 18H, PCH3), 1.82 (d, J HP
)
CH3), 9.39 (s, SiCH2CH3), 17.40 (d, J CP ) 40.2, PCH3), 29.41,
28.59, 36.72 (all s, CH2), 87.56 (d, J CP ) 11.9, CH), 89.60 (s,
CH), 101.65 (d, J CP ) 9.6, CH), 102.93 (s, CH), 125.03 (s,
NCCH3).
9.2, 9H, PCH3), 3.15, 4.91 (both m, 2H each, CH). 31P{1H} NMR
(CD2Cl2, 293 K): δ -56.48, -46.60 (both br). 13C{1H} NMR
(CD2Cl2, 293 K): δ 18.62 (m, PCH3), 20.91 (dt, J CP ) 34.6, 2.7,
PCH3), 43.19 (m, CH), 89.12 (dt, J CP ) 5.6, 2.1, CH). Partial
P r epar ation of [Ir H{Si(OMe)3}(1,2,5,6-η-C8H12)(NCCH3)-
(P Me3)]BF 4 (12). The compound was prepared as a pale
yellow solid following the procedure described for 11, by using
1 (125 mg, 0.25 mmol) and HSi(OMe)3 (63 µL, 0.50 mmol):
yield 76 mg (61%). Anal. Calcd for C16H34BF4IrNO3PSi: C,
30.67; H, 5.47; N, 2.24. Found: C, 30.57; H, 5.46; N, 2.14. IR
data for 8: 1H NMR (CD2Cl2, 293 K): δ -14.11 (dt, J HP
148.2, 21.9, 1H, Ir-H), 1.38 (dd, J HP ) 7.7, 0.9, 9H, PCH3),
1.85 (d, J HP ) 9.7, 18H, PCH3), 3.63, 4.15, 4.30, 5.04, 6.31 (all
m, 1H each, CH). 31P{1H} NMR (CD2Cl2, 293 K): δ -55.51
)
(dd, J PP ) 20.5, 20.8), -52.85 (d, J PP ) 20.5), -51.04 (d, J PP
)
20.8). 13C{1H} NMR (CD2Cl2, 293 K): δ 15.39 (dt, J CP ) 28.8,
1.7, PCH3), 23.45 (ddd, J CP ) 36.9, 3.9, 1.7, PCH3), 23.54 (ddd,
J CP ) 37.1, 3.8, 1.7, PCH3), 52.92 (d, J CP ) 24.7, CH), 55.13
1
(cm-1): 2202 ν(Ir-H). H NMR (CD2Cl2, 293 K): δ -17.36 (d,
J HP ) 15.9, 1H, Ir-H), 1.68 (d, J HP ) 11.1, 9H, PCH3), 2.61
(d, J CP ) 1.2, 3H, NCCH3), 2.30-2.90 (m, 8H, CH2), 3.50 (s,
9H, SiOCH3), 4.76, 5.11, 5.35, 5.45 (all m, 1H each, CH). 31P-
{1H} NMR (CD2Cl2, 293 K): δ -33.88 (s). 13C{1H} NMR (CD2-
Cl2, 293 K): δ 3.75 (s, NCCH3), 17.15 (d, J CP ) 40.0, PMe3),
27.28 (d, J CP ) 3.0, CH2), 30.11 (s, CH2), 30.38 (d, J CP ) 2.5,
CH2), 33.94 (s, CH2), 50.45 (s, SiOCH3), 90.36 (d, J CP ) 11.0,
CH), 91.92 (d, J CP ) 9.0, CH), 103.21, 103.65 (both s, CH),
124.51 (s, NCCH3).
(d, J CP ) 26.9, CH), 93.02 (d, J CP ) 0.9, CH), 122.92 (d, J CP
4.8, CH), 135.84 (dd, J CP ) 4.4, 0.8, CH).
)
P r ep a r a tion of [Ir H2(1,2,5,6-η-C8H12)(NCCH3)(P Me3)]-
BF 4 (9). A solution of 1 (125 mg, 0.20 mmol) in acetone (4 mL)
was stirred under dihydrogen atmosphere (P ) 1 atm) for 1 h
at 253 K. The resulting pale yellow solution was concentrated
to ca. 0.5 mL, and diethyl ether was slowly added to give a
white solid. The solid was separated by decantation, washed
with ether, and dried in vacuo: yield 59 mg (70%). Anal. Calcd
for C13H26BF4IrNP: C, 30.84; H, 5.18; N, 2.77. Found: C, 31.14;
H, 4.98; N, 2.33. IR (cm-1): 2330 ν(CtN), 2209 ν(Ir-H). 1H
NMR (CD2Cl2, 243 K): δ -17.01 (d, J HP ) 18.0, 1H, Ir-H),
-12.70 (d, J HP ) 21.0, 1H, Ir-H), 1.62 (d, J HP ) 11.0, 9H,
PCH3), 1.98-2.58 (m, 8H, CH2), 2.64 (s, 3H, NCCH3), 4.57 (m,
2H, CH), 4.78 (m, 1H, CH), 5.33 (m, 1H, CH). 31P{1H} NMR
(CD2Cl2, 243 K): δ -34.21 (s). 13C{1H} NMR (CD2Cl2, 243 K):
δ 2.77 (s, NCCH3), 18.22 (d, J CP ) 40.7, PCH3), 27.75 (s, CH2),
29.27 (d, J CP ) 1.2, CH2), 29.47 (d, J CP ) 2.3, CH2), 34.81 (s,
P r ep a r a tion of [Ir H(SiP h 3)(1,2,5,6-η-C8H12)(NCCH3)-
(P Me3)]BP h 4 (13). The procedure described for 11, using
compound 1 (125 mg, 0.25 mmol) and HSiPh3 (64.5 mg, 0.25
mmol) as starting materials, afforded a yellow oil. This oil was
dissolved in methanol at 233 K and treated with an excess of
NaBPh4 to afford a yellow solid. The solid was separated by
decantation, washed with methanol, and dried in vacuo: yield
127 mg (51%). Anal. Calcd for C55H60BIrNPSi: C, 66.25; H,
6.06; N, 1.40. Found: C, 66.67; H, 6.32; N, 1.89. IR (cm-1):
1
2264 ν(Ir-H). H NMR (CD2Cl2, 243 K): δ -16.53 (d, J HP
)
18.0, 1H, Ir-H), 0.93 (d, J HP ) 10.4, 9H, PCH3), 1.60 (m, 2H,
CH2), 1.80 (s, 3H, NCCH3), 2.02, 2.14, 2.39, 2.49, 2.78, 3.13
(all m, 1H each, CH2), 3.58 (m, 1H, CH), 4.75 (m, 2H, CH),
5.16 (m, 1H, CH). 31P{1H} NMR (CD2Cl2, 243 K): δ -39.93
(s). 13C{1H} NMR (CD2Cl2, 243 K): δ 2.86 (s, NCCH3), 16.00
(d, J CP ) 41.0, PCH3), 25.85, 25.97, 30.34, 38.20 (all s, CH2),
91.55 (d, J CP ) 8.0, CH), 92.48 (d, J CP ) 11.8, CH), 98.70,
103.02 (both s, CH), 124.55 (s, NCCH3). The NMR signals
corresponding to phenyl groups have been omitted.
CH2), 88.65 (s, CH), 89.24 (d, J CP ) 7.6, CH), 89.68 (d, J CP
5.4, CH), 89.94 (s, CH), 123.63 (s, NCCH3).
)
P r ep a r a tion of [Ir H(1-K-4,5-η-C8H13)(NCCH3)2(P Me3)]-
BF 4 (10). A solution of 1 (125 mg, 0.20 mmol) in acetonitrile
(4 mL) was stirred under dihydrogen atmosphere (P ) 1 atm)
for 15 min at room temperature. The solution was concentrated
to ca. 0.5 mL, and diethyl ether was added to give a yellow
solid. When the solid was separated by decantation, washed
with diethyl ether, and taken to dryness, it transformed into
a yellow oil. This oil could be dissolved and precipitated as a
yellow solid, although again it became an oil after isolation.
The NMR analysis of this oil in CDCl3 at 233 K showed the
[Ir H(SiP h 3)(1,2,4,5-η-C8H12)(NCCH3)(P Me3)]BP h 4 (14).
A NMR tube containing a solution of 13 in CD2Cl2 (0.5 mL)
was placed at 273 K for 4 h. After this period of time the NMR
spectra of the resulting solution revealed the presence of a
mixture containing compound 13 (ca. 50% of the reaction
mixture) and two new species 14 and 15 in approximately 1:1
molar ratio. The evolution of this solution at 293 K for 1 h
quantitatively produced complex 15. Partial data for 14: 1H
NMR (CD2Cl2, 233 K): δ -16.51 (d, J HP ) 18.0, 1H, Ir-H),
1.53 (d, J HP ) 10.9, 9H, PCH3), 2.11 (s, 3H, NCCH3), 3.60, 4.36
(both m, 1H each, CH), 4.90 (m, 2H, CH). 31P{1H} NMR (CD2-
Cl2, 233 K): δ -35.46 (s). 13C{1H} NMR (CD2Cl2, 233 K): δ
3.28 (s, NCCH3), 16.79 (d, J CP ) 40.9, PCH3), 26.79, 27.06,
29.56, 36.86 (all s, CH2), 90.03 (d, J CP ) 9.4, CH), 91.61 (d,
J CP ) 11.4, CH), 99.45, 103.59 (both s, CH), 123.41 (s, NCCH3).
1
presence of 10 as the only reaction product. H NMR (CDCl3,
233 K): δ -20.35 (dd, J HP ) 22.2, J HH ) 3.9, 1H, Ir-H), 1.11
(m, 2H, CH2), 1.55 (m, 1H, CH), 1.67 (d, J HP ) 8.7, 9H, PCH3),
1.70, 1.80, 2.05 (all m, 2H each, CH2), 2.24, 2.43 (both s, 3H
each, NCCH3), 2.45, 3.21 (both m, 1H each, CH2), 4.75, 4.78
(both m, 1H each, CH). 31P{1H} NMR (CDCl3, 233 K): δ -29.79
(s). 13C{1H} NMR (CDCl3, 233 K): δ 2.77, 3.14 (both s, NCCH3),
4.81 (d, J CP ) 3.7, Ir-CH), 15.25 (d, J CP ) 38.7, PCH3), 24.75,
30.59, 39.05 (all s, CH2), 24.88 (d, J CP ) 2.3, CH2), 41.23 (d,
J CP ) 5.3, CH2), 84.32 (d, J CP ) 10.1, CH), 87.40 (d, J CP ) 14.7,
CH), 118.36, 121.48 (both s, NCCH3).
P r ep a r a tion of [Ir H(SiEt3)(1,2,5,6,-η-C8H12)(NCCH3)-
(P Me3)]BF 4 (11). A solution of 1 (125 mg, 0.20 mmol) in CH2-
Cl2 (2 mL) at 233 K was treated with HSiEt3 (31 µL, 0.20
mmol) and stirred for 10 min. The resulting yellow solution
was concentrated to ca. 0.5 mL, and diethyl ether was added
to give a pale yellow solid. The solid was separated by
decantation, washed with diethyl ether, and dried in vacuo:
yield 83 mg (67%). Anal. Calcd for C19H40BF4IrNPSi: C, 36.77;
H, 6.50; N, 2.26. Found: C, 37.27; H, 6.91; N, 2.41. IR (cm-1):
P r ep a r a tion of [Ir H(SiP h 3)(1,2,3,4-η-C8H12)(NCCH3)-
(P Me3)]BP h 4 (15). A solution of 13 (100 mg, 0.10 mmol) in
CH2Cl2 (2 mL) was allowed to react at room temperature for
1 h. The resulting solution was concentrated to ca. 0.5 mL,
and diethyl ether was added to give a pale yellow solid. The
solid was separated by decantation, washed with diethyl ether,
and dried in vacuo: yield 83 mg (83%). Anal. Calcd for C55H60
-
BIrNPSi: C, 66.25; H, 6.06; N, 1.40. Found: C, 66.05; H, 5.74;
N, 1.20. 1H NMR (CD2Cl2, 233 K): δ -16.46 (d, J HP ) 12.9,
1H, Ir-H), 1.31 (d, J HP ) 10.8, 9H, PCH3), 1.83 (s, 3H, NCCH3),
2.25-2.65 (m, 8H, CH2), 4.40 (m, 2H, CH), 4.81, 4.98 (both m,
1H each, CH). 31P{1H} NMR (CD2Cl2, 233 K): δ -32.88 (s).
13C{1H} NMR (CD2Cl2, 233 K): δ 2.56 (s, NCCH3), 14.41 (d,
J CP ) 40.6, PCH3), 27.76, 29.60, 30.89, 33.05 (all s, CH2), 91.23,
2206 ν(Ir-H). 1H NMR (CDCl3, 233 K): δ -17.19 (d, J HP
)
18.0, 1H, Ir-H), 0.51, 0.68 (both m, 3H each, SiCH2CH3), 0.87
(m, 9H, SiCH2CH3), 1.65 (d, J HP ) 10.3, 9H, PCH3), 2.00 (m,
1H, CH2), 2.24-2.60 (m, 4H, CH2), 2.63 (s, 3H, NCCH3), 2.67
(m, 2H, CH2), 3.08 (m, 1H, CH2), 4.39, 5.11, 5.19, 5.29 (all m,
1H each, CH). 31P{1H} NMR (CDCl3, 233 K): δ -35.4 (s). 13C-
{1H} NMR (CD2Cl2, 233 K): δ 4.77 (s, NCCH3), 7.65 (m, SiCH2-
92.65 (both s, CH), 93.91 (d, J CP ) 13.9, CH), 98.15 (d, J CP
)